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Abstract
Purpose: We aimed to determine the contribution of the apparent diffusion coefficient (ADC) value in the detection 
of axillary lymph node metastasis.
Material and methods: Breast magnetic resonance of 58 patients, performed in the radiology clinic of our hospital 
between 2015 and 2017 were examined retrospectively, and 43 lymph nodes in 43 patients were included in the study. 
They were evaluated morphologically on T1W and T2W sequences, and the lymph nodes showing rounded shape, 
focal or diffuse cortical thickness of more than 3 mm, and partial or total effacement of fatty hilum were included in 
the study. Subsequently, their ADC values were measured.
Results: There were 43 lymph nodes, 20 of which were malignant and 23 of which were benign. While the mean ADC 
value of malignant axillary lymph nodes was 0.749 10–3 mm2/s (0.48-1.342), it was 0.982 10–3 mm2/s (0.552-1.986) 
for benign lymph nodes. When the ADC cut-off value was taken as ≤ 0.753 × 10–3 mm2/s, its discrimination power 
between benign and malignant axillary lymph nodes was as follows: sensitivity – 60%; specificity – 91.3%; accuracy 
– 76.7%; positive predictive value – 85.7%; and negative predictive value – 72.4%.
Conclusions: There was no significant difference between mean ADC value of 12 lymphadenopathies (LAP) associated 
with inflammatory breast diseases (granulomatous mastitis and acute suppurative mastitis) and mean ADC value of 
metastatic lymph nodes. However, the ADC value of lymph nodes showing thickened cortex due to systemic inflamma-
tory diseases was over 1, and there was a statistically significant difference when compared with metastatic lymph nodes.
Key words: axillary LAP, breast cancer, diffusion-weighted imaging (DWI), apparent diffusion coefficient (ADC). 
Correspondence address: 
Dr. Berrin Erok, Cihanbeyli State Hospital, Radiology, Konya, Turkey, e-mail: drberrinerok@hotmail.com
Authors’ contribution: 
A Study design ∙ B Data collection ∙ C Statistical analysis ∙ D Data interpretation ∙ E Manuscript preparation ∙ F Literature search ∙ G Funds collection
Introduction
The most important prognostic factor in breast cancer is 
whether or not the axillary lymph nodes include metasta-
sis, and if so, the number of metastatic lymph nodes. When 
the five-year survival for patients with negative axillary 
lymph nodes is 82.8%, it decreases proportionally with the 
number of metastatic nodes [1-4]. The presence of meta-
static lymph nodes alters the treatment modality and the 
surgical method. Therefore, preoperative diagnosis of nod-
al metastasis is extremely important. Axillary dissection is 
an invasive procedure which may be associated with com-
plications reducing the quality of life [5,6]. The sentinel 
lymph node (SLN) procedure emerged to reduce unnec-
essary axillary lymphadenectomy, and the associated mor-
bidity was shown to be successful in patients with breast 
cancer; however, when the literature was analysed, it was 
seen that the rate of false negativity was higher than ex-
pected. For this reason, preoperative radiological diagnosis 
of nodal metastasis with high accuracy is very important. 
To that end, the main imaging modality is ultrasound (US) 
imaging. On US the sensitivity and specificity is increased 
by using morphological criteria as a base in distinction of 
benign and malignant lymph nodes. In differentiation of 
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benign and malignant breast lesions, by making post-con-
trast kinetic analysis in addition to morphological criteria 
in conventional magnetic resonance (MR) imaging, the 
sensitivity is increased to approximately 86-100%, but the 
specificity does not show a similarly high rate. Therefore, 
in order to increase specificity, additional sequences were 
sought [7,8]. It was shown that measurement of the ap-
parent diffusion coefficient (ADC) obtained from diffu-
sion-weighted sequences (DWI) added to conventional 
MR increases specificity and provides more accurate dif-
ferentiation of benign and malignant breast lesions [7-11]. 
However, evaluation of axillary lymphadenopathies (LAP) 
with DWI is still under study. In our study, we aimed to 
determine the contribution of the ADC value to morpho-
logical criteria evaluated with conventional MR imaging in 
the detection of nodal metastasis. 
Material and methods
Breast MR of 58 patients, performed in the radiology clin-
ic of our hospital between 2015 and 2017, were examined 
retrospectively, and the lymph nodes having focal or dif-
fuse cortical thickness more than 3 mm were included in 
the study. 
Approval was obtained from our hospital’s Ethics 
Board (date: 04.04.2018, decision: 20), and informed writ-
ten consent was obtained from each patient. 
At first, the lymph nodes were evaluated morpholog-
ically on T1W and T2W images, and the lymph nodes 
showing rounded shape, focal or diffuse cortical thickness 
more than 3 mm, and partial or total effacement of fatty 
hilus were included in the study. After that, without know-
ing about primary breast diseases, follow-up period, and 
pathological results, they were evaluated on DWI sequences 
and their ADC values were measured. The lymph nodes 
of 12 patients, which were apparent on conventional MR 
sequences, were not visualised on DWI possibly due to in-
sufficient resolution especially for the nodes smaller than 
5 mm in diameter and motion artefact, so they were ex-
cluded from the study. Additionally, because three patients 
had received neoadjuvant chemotherapy, they were also 
excluded from the study. As a result, a total of 43 lymph 
nodes in 43 patients were included in the study, and the 
mean age was 44.42 ± 12.15 years (26-73). Thirty-two out of 
43 patients had been diagnosed histopathologically by 
surgical excisional biopsy or thick needle biopsy, and the 
remaining 11 lymph nodes had been evaluated firstly as be-
nign and during a one-year follow-up period at six-month 
intervals they were accepted as benign as they decreased in 
size and the cortical thickness returned to normal. 
Magnetic resonance imaging
All examinations were performed with 1.5 Tesla (T) MRI 
equipment (GE Signa HDx, GE Medical Systems, USA) us-
ing an eight-channel phased array breast surface coil. Care 
was taken to perform the breast MRI of pre-menopausal 
women between the 5th and 15th days of the menstrual cy-
cle. Conventional contrast MRI images were obtained with 
the following technique: axial fat-suppressed T2-weight-
ed turbo spin-echo (repetition time/echo time; TR/TE), 
4500 ms/97 ms, 330 mm field of view (FOV), number of 
excitations (NEX): 1, matrix, 384 × 512; slice thickness of 
3 mm with a 1 mm intersection gap and fat-suppressed 
T1-weighted (TR/TE, 720 ms/20 ms; 330 mm FOV, NEX: 
2, matrix, 320 × 320; slice thickness of 3 mm), and fat-sup-
pressed 3D T1-weighted images (4.3 ms/1.4 ms; flip-angle, 
12°; a FOV of 320 mm; matrix, 307 × 512; signal average 1; 
slice thickness, 1.5 mm fast low-angle shot [FLASH]) with 
and without contrast. Sagittal fat-supressed 3D T1-weight-
ed images were obtained six minutes after contrast ma-
terial injection in addition to axial dynamic contrast-en-
hanced images. The contrast agent (Dotarem, Laboratoire 
Guerbet, Roissy, France) was administered at 0.2 mmol/
kg via automatic syringe, followed by 15-20 cc of saline 
for homogeneous distribution of the contrast substance. 
DWI echo-planar images (TR/TE 8500/70, FOV of 330 mm, 
matrix 192 × 192, NEX: 1, sectional thickness 4.5 mm with 
a 1 mm intersection gap) were obtained in the axial plane 
before contrast administration. DWI were obtained by dif-
fusion gradients between 0 and 1000 s/mm2 b-values.
Apparent diffusion coefficient analysis
An ADC map was automatically constructed in a commer-
cially available workstation. Mean ADC values of all lesions 
were automatically measured by using these maps according 
to the formula ADC = (lnS0 – lnS)/b (signal intensity val-
ues are measured as S0 at b = 0 s/mm2 and S at b = 1000 s/
mm2). Measurements were performed by placing a region of 
interest (ROI) of 0.5 mm diameter on lesions. ADC meas-
urements were performed on enhancing or solid parts of the 
lesions identified in conventional sequences. The ROI did 
not include normal parenchymal tissue, or haemorrhagic 
or necrotic areas. One radiologist with experience in breast 
MRI evaluated the images and performed measurements of 
ADC and rADC values. A minimum of three ADC meas-
urements were performed, and the lowest ADC value was 
accepted. The ADC value of the contralateral breast at the 
same level was also measured after ADC measurements 
were completed for the lesion and ROI of the same diam-
eter was used. The rADC was calculated as the mass ADC 
value divided by the ADC value of adjacent parenchyma. In 
addition, the maximum diameters of the tumours on sagit-
tal and axial planes were measured and the mean of these 
values were expressed as “mean maximum size”.
Statistical analysis
SPSS 25.0 (IBM Corparation, Armonk, New York, Unit-
ed States) software was used for the analysis of variables. 
The conformity of normal distribution of data was evalu-
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ated by Shapiro-Wilk test and homogeneity of variances 
by Levene. While comparing benign and malign groups 
with each other according to age-independent-samples 
t-test with Bootstrap results were used, and for long 
and short diameter and ADC comparison Mann-Whit-
ney U test with Monte Carlo simulation technique was 
used. In the comparison of hilux situation with malignity 
Fisher exact test was verified by Exact results. Odds ratio 
with confidence interval was used in order to show how 
many more times the hilum situation affects malignity. 
The relationship between the classification with cut-off 
value calculated according to ADC variable and the real 
classification was defined by examination of sensitivity, 
specificity, positive predictivity, negative predictivity, di-
agnostic accuracy, and ROC (receiver operating curve) 
analysis. Quantitative variables were presented as mean 
± SD (standard deviation), minimum-maximum and 
median (minimum/maximum), and categorical variables 
were presented as n (%). Variables were examined in con-
fidence interval of 95%, and the significance level for the 
study was set as p < 0.05.
Results
In our study there were 43 lymph nodes, 20 of which 
were malignant and 23 of which were benign. The mean 
age of the patients with benign lymph nodes was 39.52 ± 
9.54 years (26-61), and the mean age of the patients with 
malignant lymph nodes was 50.05 ± 12.60 years (27-73). 
The mean age of the malignant group was significantly 
higher than that of the benign group (p = 0.005) (Figure 1).
While the mean length of the long diameter of ma-
lignant lymph nodes was 15 mm (7-34), it was 14 mm 
(7-30) for benign lymph nodes. There was no statistically 
significant difference between the two groups (p = 0.492). 
The mean length of the short diameter of malignant 
lymph nodes was 9 mm (5-23), and it was 8 mm (5-14) for 
benign lymph nodes. There was no statistically significant 
difference between the two groups (p = 0.539).
The mean ADC value of malignant axillary lymph 
nodes was 0.749 10–3 mm2/s (0.48-1.342), and it was 
0.982 10–3 mm2/s (0.552-1.986) for benign lymph nodes. 
There was a statistically significant difference between the 
two groups (p < 0.001) (Figure 2). 
When the ADC cut-off value was taken as ≤ 0.753 × 
10–3 mm2/s, its discriminative power between benign and 
malignant axillary lymph nodes was as follows: sensitiv-
ity – 60%, specificity – 91.3%, accuracy – 76.7%, positive 
predictive value – 85.7%, and negative predictive value – 
72.4% (Figures 3 and 4).
Discussion
Breast cancer is the most common type of cancer in wom-
en, and despite advances in diagnosis and treatment, it is 
the second most common cause of cancer-related deaths 
after lung cancer [12]. Being the most important prognos-
tic factor, the presence of malignant axillary lymph nodes 
in breast cancer plays a critical role in staging, treatment 
planning, and long-term survival [1,13]. On mammogra-
phy, the axillary region can be evaluated partially. Classi-
Figure 1. Age distribution
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cally, normal axillary lymph nodes are seen as oval-shaped 
opacities having a maximum diameter less than 2 cm and 
radiolucent notch. Increased size, number, density, and ef-
facement of the radiolucent hilum cause suspicion of being 
pathological. It is known that the best modality in the eval-
uation of axilla is US. However, the sensitivity and spec-
ificity of US in the detection of axillary metastatic lymph 
nodes are variable and contradictory [14]. US is operator 
dependent and is insufficient in the evaluation of deeply lo-
cated lymph nodes [15]. Biopsy is the gold standard modal-
ity in the evaluation of axillary LAP. However, it is both an 
invasive procedure and has a high false negativity rate due 
to possible wrong sampling [16]. In recent years, in order 
to increase sensitivity and specificity, DWI has been added 
to conventional breast MR. In many studies, the benefit of 
DWI in the differentiation of malignant and benign breast 
lesions as well as following the response to treatment has 
been shown, and so it is included in routine MR protocols 
in many centres [17-20]. The evaluation of axillary LAP 
by DWI is still under study and is controversial.
When water molecules are placed in a container, they 
undergo Brownian motion without any obstacles. This 
motion, which is not restricted by anything, is called free 
diffusion [21]. The DWI value shows the level of diffu-
sion of water molecules in tissues. The diffusion of water 
in tissues was restricted basically by cell membranes and 
cellularity of the tissue. When the cell membranes are de-
stroyed, water molecules move freely or when the cellular-
ity increases, which means the number of cell membranes 
increases (in tumoral processes) the motion of water mol-
ecules restricted [11]. In order to measure diffusion in tis-
sues, before and after 180º RF pulses, two gradients having 
equal force and time (diffusion gradients) are applied in 
EPI sequences. These gradients should be strong enough 
to determine the movement dependent on diffusion. 
The diffusion weight factor (b value) shows the extent to 
which the sequence is sensitive to the diffusion. When 
the b value is low, perfusion and the T2 time affect diffu-
sion, and the diffusion weight of the sequence decreases. 
The perfusion of malignant tumours is markedly higher 
than that of the benign ones, and so at low b values the 
ADC of malignant lesions were measured as higher than 
it is. However, if the b value is equal to or higher than 
600 s/mm², the effect of perfusion is shown to be mini-
mal and can be ignored [22]. Because, when the b value 
increases the spatial resolution decreases significantly, and 
when the b value decreases then the perfusion effect ap-
pears, in our study the b value was taken as 1000 s/mm².
ADC is the mathematical expression of diffusion ob-
tained as a result of marking the signal losses on the map 
after the application of diffusion gradients. In order to ob-
tain an ADC map two imagings with and without diffu-
sion gradient are performed. The ADC value is the nega-
tive logarithm of the signal ratios of these two images [23]. 
The ADC value of free water molecules at 37ºC is reported 
to be 3.0 × 10–3 mm2/s. This value is taken as the reference 
point, and it is the value at which the diffusion is maxi-
mum. When there is restriction to diffusion the ADC value 
decreases [11]. 
In most of the studies conducted in the literature, pa-
tients with diagnosis of invasive breast carcinoma were 
taken as a study group and by comparing ADC values 
of axillary lymph nodes, its contribution to differentiation 
of malignant and benign lymph nodes was investigated 
[24-26]. In the study conducted by Kim et al. [24] the ADC 
value for metastatic lymph nodes was 0.91 × 10–3 mm2/s 
and it was 1.27 × 10–3 mm2/s for benign lymph nodes; in the 
study of Razek et al. [25] the ADC value for metastatic lymph 
nodes was 1.08 × 10–3 mm2/s and it was 1.15 × 10–3 mm2/s 
for benign lymph nodes; in the study of Chung et al. [26] 
the ADC value for metastatic lymph nodes was 0.69 × 10–3 
mm2/s and it was 1.04 × 10–3 mm2/s for benign lymph 
nodes; and in the study conducted by Hazanzadeh et al. 
[27] the ADC value for metastatic lymph nodes was 0.824 
× 10–3 mm2/s and it was 1.098 × 10–3 mm2/s for benign 
lymph nodes. In these studies, the ADC values were sig-
nificantly lower in metastatic lymph nodes. In the detec-
tion of metastatic axillary lymph nodes the accuracy rate 
of the ADC value was reported to be 80% in the study of 
Scaraleno et al. [28]. In the study of Choi et al. the malig-
nant possibility of the axillary lymph nodes having corti-
cal thickness more than 3 mm was found to be 4.4 times 
higher than that of the axillary lymph nodes with cortical 
thickness less than 3 mm, and in ultrasound evaluation 
the cortical thickness was defined as the most accurate 
sign in detection of metastasis [29]. In addition to that, in 
the study of Scaranelo et al. a higher rate of being asso-
ciated with malignity was established for axillary lymph 
nodes with cortical thickness more than 3 mm [28].
By taking as references these data from the literature, 
we evaluated all axillary lymph nodes with cortical thick-
ness more than 3 mm without any consideration about 
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primary breast disease, and then their ADC values were 
measured without knowing about primary breast disease, 
follow-up period, and pathology results [29]. 
Morphologically the most common cause of malig-
nant-looking LAP is inflammatory pathologies. In the 
study conducted by Wang et al. [30] no significant mor-
phological difference was established between the lymph 
nodes that underwent a change due to metastasis and in-
flammatory pathologies. In our study, there were 12 LAPs 
associated with inflammatory breast diseases (pathologi-
cally proven nine granulomatous mastitis and three acute 
suppurative mastitis), and their mean ADC value was 
0.868 × 10–3 mm2/s. No statistically significant difference 
was found when compared with mean ADC value of met-
astatic axillary lymph nodes. However, in the lymph nodes 
with thickened cortex associated with systemic inflamma-
tory diseases, the value of ADC was over 1 mm2/s and there 
was a statistically significant difference when compared 
with mean ADC values of metastatic axillary lymph nodes. 
In the study conducted by Wang et al. [30] and Van-
dacavaye et al. [31] the signal of both the malignant and 
inflammatory lymph nodes was hyperintense on DWI, 
and it was specified that they were not differentiated from 
each other by using DWI signal. In also our study, all the 
lymph nodes showed hyperintensity on DWI in accord-
ance with the literature.
The main limitations of our study are: the limited num-
ber of patients, exclusion of lymph nodes with diameter less 
than 5 mm, even if they have rounded shape and effaced 
hilum because of not being visualised on DWI, and the va-
lidity of the cut-off DC value only for the imaging protocols 
performed with the b values defined for our device.
Conclusions
ADC values of axillary lymph nodes secondary to sys-
temic inflammatory processes have been found over 1 × 
10–3 mm2/s and were significantly higher when compared 
with the ADC values of metastatic LAP (Figure 5), and 
the malignant-benign distinction could be made. How-
ever, in the axillary LAP associated with inflammatory 
pathologies of the breast, like granulomatous mastitis and 
acute suppurative mastitis (Figure 6), there was no signif-
icant difference between their ADC values, and the ma-
lignant-benign distinction could not be made. We believe 
that this information will be obtained more accurately and 
reliably in studies conducted with larger patient series.
Disclosure
The authors declare no conflicts of interest.
Figure 5. 10 × 7 mm right axillary lymphadenopathies with diffuse cortical thickening, seen as hyperintense on diffusion-weighted imaging and hypoin-
tense on apparent diffusion coefficient (restricted diffusion) (ADC: 0.584 × 10–3 mm2/s) (pathology: carcinoma metastasis from ipsilateral breast)
A B
Figure 6. 14 × 12 mm sized left axillary lymphadenopathies with rounded shape, seen as hyperintense on diffusion-weighted imaging and hypointense on 
apparent diffusion coefficient (restricted diffusion) (ADC: 0.768 x 10–3 mm2/s) (pathology: reactive hyperplasia associated with acute suppurative mastitis 
in the ipsilateral breast) 
A B
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